C12N 2740/14071
Demonstrated in vivo effect
C12N2740/14071 (Demonstrated in vivo effect) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 4
- Assignees
- 5
- Inventors
- 7
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Vaccine against bovine leukemia virus26 Oct 2021US 11,154,611 B2Instituto Nacional De Tecnologia Agropecuaria
- Chimeric peptides against HTLV-122 Sep 2020US 10,780,159 B2
- Vaccine against bovine leukemia virus24 Jul 2018US 10,029,006 B2Instituto Nacional De Technologia Agropecuaria
- Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 15 Jun 2018US 9,987,351 B2Theravectys
- Vaccine against bovine leukemia virus3 Jan 2019US 2019/0000963 A1Instituto Nacional De Tecnologia Agropecuaria
- Chimeric peptides against htlv-112 Apr 2018US 2018/0099042 A1
- Lentiviral vectors for generating immune responses against human t lymphotrophic virus type 117 Nov 2016US 2016/0331831 A1Theravectys
- Vaccine against bovine leukemia virus18 Feb 2016US 2016/0045593 A1Instituto Nacional De Tecnologia Agropecuaria
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.